The U.S. military has lessened its stringent health requirements to cope with lagging recruitment numbers, contributing to an ...

(The Center Square) - Sen. Ruben Gallego, D-Arizona, announced his support for a bill aimed at helping America’s obesity ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Your bedroom lighting choices could be silently damaging your health every night. Research shows just one night of moderate light exposure during sleep raises insulin resistance and prevents proper ...

Sedentary lifestyles, unhealthy eating and genetic factors are major reasons for the problem, which needs to be tackled on a ...

Adolescents face significant barriers to obesity medication access, despite a surge in prescriptions. Discover the ...

Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as ...

This expert-backed guide compares bariatric surgery and weight loss drugs highlighting long-term outcomes health benefits and ...

Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...

Eli Lilly & Co. increased sales of weight-loss and diabetes drug Mounjaro 60% in India in May from April in its second full ...

The US drugmaker sold ₹12.6 crore ($1.5 million) worth of the injections last month, according to market analysis firm ...